Invesco Pharmaceuticals ETF
PJP
PJP
99 hedge funds and large institutions have $107M invested in Invesco Pharmaceuticals ETF in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.14% less ownership
Funds ownership: 14.37% → 14.23% (-0.14%)
3% less capital invested
Capital invested by funds: $110M → $107M (-$3.35M)
38% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 34
Holders
99
Holding in Top 10
1
Calls
$1.72M
Puts
$458K
Top Buyers
| 1 | +$3M | |
| 2 | +$1.61M | |
| 3 | +$1.54M | |
| 4 |
FSA
Financial Sense Advisors
San Diego,
California
|
+$1.37M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.12M |
Top Sellers
| 1 | -$6.32M | |
| 2 | -$2.87M | |
| 3 | -$2.79M | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$1.44M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.32M |